CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

por Frantzi, Maria, Gomez Gomez, Enrique, Blanca Pedregosa, Ana, Valero Rosa, José, Latosinska, Agnieszka, Culig, Zoran, Merseburger, Axel S., Luque, Raul M., Requena Tapia, María José, Mischak, Harald, Carrasco Valiente, Julia
Publicado 2019

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination

por Frantzi, Maria, Culig, Zoran, Heidegger, Isabel, Mokou, Marika, Latosinska, Agnieszka, Roesch, Marie C., Merseburger, Axel S., Makridakis, Manousos, Vlahou, Antonia, Blanca-Pedregosa, Ana, Carrasco-Valiente, Julia, Mischak, Harald, Gomez-Gomez, Enrique
Publicado 2023

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

por Gómez‐Gómez, Enrique, Carrasco‐Valiente, Julia, Campos‐Hernández, Juan Pablo, Blanca‐Pedregosa, Ana Maria, Jiménez‐Vacas, Juan Manuel, Ruiz‐García, Jesus, Valero‐Rosa, Jose, Luque, Raul Miguel, Requena‐Tapia, María José
Publicado 2018

Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer

por Gómez‐Gómez, Enrique, Jiménez‐Vacas, Juan M., Carrasco‐Valiente, Julia, Herrero‐Aguayo, Vicente, Blanca‐Pedregosa, Ana M., León‐González, Antonio J., Valero‐Rosa, José, Fernández‐Rueda, José L., González‐Serrano, Teresa, López‐Miranda, José, Gahete, Manuel D., Castaño, Justo P., Requena‐Tapia, María J., Luque, Raúl M.
Publicado 2018